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The mammalian transcription  factor  E2F  binds  to 
several  cellular  proteins  including Rb, p107, cyclin A, 
cyclin E, and  p33cdk2  protein  kinase  in a stage-spe- 
cific manner during cell cycle. Its recognition se- 
quence, TTTCGCGC, is  present  in  two of the human 
adenovirns early promoters  and in several  promoters 
of cellular genes whose products are implicated in  the 
control of cell proliferation. These observations sug- 
gest that  E2F may play an  important  role in cell-cycle 
regulation  and prompted us to  ask  whether  E2F-like 
activities are present  in yeast. We found that  the  E2F 
motif can function as an  activating sequence in Schi- 
zosaccharomyces  pombe when cloned upstream of a 
reporter gene. Consistent with  this, the expression of 
adenovirus E2 promoter in S. pombe was dependent on 
both E2F motifs of this  promoter. A protein, spESF, 
that binds to the  E2F  site  was  partially  purified  from 
S. pombe using DNA-affinity chromatography. The 
binding specificity of this  protein  was compared to that 
of human E2F using a number of mutant E2F  sites as 
competitors. These studies showed that  spE2F recog- 
nizes a sequence closely related  to  the E2F site. Ultra- 
violet cross-linking  and  Southwestern blot studies  in- 
dicated that  the molecular size of spE2F  is 30 kDa. 
Previous  studies  have shown that a  cis-acting element, 
ACGCGTNA, also called Mu1 cell cycle box, or MCB, 
is critical for the regulated expression of cell cycle 
related genes both in fission and budding yeast. In S. 
pombe, the cdclO gene product  binds to this element 
and  controls  the cell cycle related genes. Electropho- 
retic mobility shift assays and molecular size determi- 
nation  studies  indicated that spE2F  is  different  from 
that encoded by cdcl0. Thus, our  studies suggest that 
spE2F is a novel transcription  factor. We discuss these 
results  in  light of recent  observations  about  the p riod- 
ically expressed genes involved in the cell cycle pro- 
gression in yeast. 
E2F is a cellular transcription factor first identified in 
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studies of the  human adenovirus E2-early  promoter (1). The 
E2F recognition sequence TTTCGCGC, or a closely related 
sequence is found in two E1A-responsive adenovirus early 
promoters, E1A and E2-early  (referred to as E2 promoter in 
this  paper)  and several cellular promoters such as dihydrofo- 
late reductase and c-myc (reviewed in Refs. 2 and 3). The 
activity of E2F is regulated by a  number of factors. In virus- 
infected cells, DNA binding activity of E2F is increased 
considerably by the 17-kDa polypeptide encoded by the ade- 
novirus early region 4 and also by the viral pre-early gene 
E1A (2, 3). In mammalian cells, the tumor suppressor gene 
product Rb physically interacts with E2F (4-6) or another 
transcription factor,  DRTF1, which is related to E2F (7, 8); 
this  interaction may influence the activity of these transcrip- 
tion factors  during cell cycle progression. Other studies have 
shown that  E2F is present as  a complex with cyclin A, cyclin 
E, p107, and p33cdk2 protein  kinase,  indicating the existence 
of other mechanisms to control the E2F activity (9-15). In 
addition, E2F complexes are regulated during the differentia- 
tion of rapidly growing teratocarcinoma  stem cells into post- 
mitotic differentiated cells (16). Thus, E2F may play an 
important role in the control of proliferation of mammalian 
cells. 
Regulation of transcription of genes involved in cell  cycle 
control has been reported both  in budding and fission yeast. 
In Saccharomyces cerevisiae, a sequence motif ACGCGTNA, 
also known as the MluI cell-cycle box or MCB,’ has been 
identified as  an upstream  activator  element  in  a  number of 
promoters of genes that  are coordinately regulated in the GI/ 
S phase of the cell cycle (17-19). Cell cycle-regulated tran- 
scription of these genes is controlled by a  transcription com- 
plex called DNA synthesis complex or DSC-1 (19). TWO 
transcription factors, p120 and SWIG, are believed to be a 
part of this transcription complex (20-24). Currently, the 
relationship between p120 and  another transcription factor, 
SW14, is not clear. Biochemical and genetic studies suggest 
that  the SWIG protein of the DSC-I complex binds to  the 
MCB sequence (21,22). Recent  studies  indicate that  the MluI 
system is conserved in the distantly related fission yeast 
Schizosacchuromyces  pombe. The cdc22 that encodes the large 
subunit of the ribonucleotide reductase is expressed at  the 
GI/S phase  boundary in S. pombe (25). The promoter of this 
gene contains 7  MCB sequences (26). A DSC-l-like activity 
The abbreviations used are: MCB, MluI cell  cycle box; DSC,  DNA 
synthesis complex; nt, nucleotide(s); PIPES, 1,4-piperazinedietha- 
nesulfonic acid; DTT, dithiothreitol; EMSA, electrophoretic mobility 
shift assay; Chaps, 3-[(3-cholamidopropyl)dimethylammonio]-l-pro- 
panesulfonic acid; PAGE, polyacrylamide gel electrophoresis. 
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was detected in S. pombe that recognizes the MCB sequences 
of the cdc22 promoter; the  cdcl0 protein required for the  start 
and  entry  into S phase in S. pombe is a part of this activity 
(26). Another protein, Sctl, has also been shown to be a part 
of the  DSC-l-like activity in S. pombe indicating that addi- 
tional proteins may be present in the DSC-1 complex in 
fission yeast (27). Sctl may exist as a complex with cdcl0 
protein  (27). 
Thus,  it appears that  there  are striking  similarities between 
the yeast and mammalian systems with regard to  the regula- 
tion of the expression of genes involved in cell cycle control. 
In addition, it is now clear that, from yeast to man, many 
transcription  factors  are conserved throughout evolution. 
These observations prompted  us to ask whether the E2F motif 
would activate transcription in S. pombe and whether S. 
pombe cells contain  proteins that would bind to E2F motifs. 
In this paper we show that a single E2F site can activate 
transcription of a reporter gene in S. pombe when placed 
upstream of a minimal promoter. By using a DNA-affinity 
column which contains the  E2F recognition sequence, we have 
partially purified a 30-kDa protein from S. pombe, designated 
S. pombe E2F (spEZF), and compared the binding specificity 
of this protein with that of human E2F. spE2F recognizes a 
sequence closely resembling the  E2F site, and  this  transcrip- 
tion factor is different from that encoded by the cdclO  gene. 
We discuss these results in light of recent results of the 
regulation of the periodically expressed yeast genes during 
cell cycle. 
MATERIALS AND  METHODS 
Yeast Strains  and Plasmids-S. pombe strain h+, ade6-704, leul- 
32, his3-237, ura4-dB (28) was used for promoter expression studies. 
For protein purification, a protease-deficient strain, TMOll (h-, 
leu1.32) (a gift from Jo Ann Wise, Urbana-Champaign) was used. 
Plasmids which contain  a wild type adenovirus E2 promoter fused to 
a reporter gene, chloramphenicol acetyltransferase  (CAT) 
(pEZWTCAT), and the linkerscan (LS) mutant derivatives which 
individually mutate the proximal (LS -3l/-41) and  the distal (LS 
-55/-66) E2F sites and the ATF site (LS -74/-85) of the +1 
promoter have been described earlier (29, 30). The wild type (WT) 
and  mutant promoters fused to CAT coding sequences were cloned 
into an autonomously replicating yeast shuttle vector, pURA4 (31), 
using standard recombinant DNA procedures described elsewhere 
(32). Plasmid pCEH contains the TATA motif of the human a- 
chorionic gonadotropin gene promoter, which drives transcription of 
the CAT gene (33). The vector also contains the autonomously 
replicating yeast sequence am1 and  the URA3 gene for selection. 
Extract Preparation and CAT Assay-S. pombe cells (approxi- 
mately 1.5 X lo6) grown in  Edinburgh minimal medium (supplied by 
BIO 101; catalog No. 10700) were transformed with pCEH vectors 
which contained the  WT  and  the  mutant  E2F sites according to  the 
method of Okazaki et al. (34) and plated on Edinburgh minimal 
medium-agar plates  (BIO 101; catalog No. 10701) for  5 days at 30 "C. 
About 20,000 transformants were pooled from the plates with water, 
harvested and washed with water twice, and suspended in 1 ml of 1 
M sorbitol which contained 0.1 M EDTA and 14 mM Z-mercaptoeth- 
anol. The cells were converted to spheroplasts by treating with 
lyticase (Sigma, 0.1 unit per pl) for 1 h at 30 "C. The spheroplasts 
were then harvested by centrifugation at 3000 rpm for 10 min at 4 "C, 
resuspended in 1.2  ml of an extraction buffer which contained 92 mM 
Tris-HC1 (pH 7.4) and 42 mM EDTA, and sonicated on ice for 1 min 
by a  Branson sonifier 450 (output control 2.5). Protein  concentrations 
in the extracts were determined according to Bradford (35) using the 
Bio-Rad protein assay kit (catalog No. 500-0006). CAT activity in 
the lysates was determined by an enzyme immunoassay using the 
CAT-ELISA kit of Boehringer Mannheim Corp. (catalog No.  1362- 
727) under conditions exactly as recommended by the vendor. Equal 
quantities of protein were used in the CAT assays (36). 
RNA Analysis-Yeast cells were transformed with pURA4, which 
contains WT E2 CAT construct (pU4E2CAT) and  the  mutant deriv- 
atives, according to  the method of Beach and Nurse (28). Transformed 
colonies containing stably replicating plasmid were grown in YEL 
media (0.5% yeast extract and 3% glucose supplemented with 0.1 mg/ 
ml L-leucine, 0.1 mg/ml adenine, and  0.1 mg/ml uracil) at 28-30 "C 
to a density of 5 X 106/ml. Poly(A+) RNA was prepared from trans- 
formed yeast cells in the midexponential phase (31) and used for 
primer extension analysis (30). Briefly, a 27-nucleotide (nt)-long CAT 
primer corresponding to nucleotides +110 to +136 (with reference to 
+1 cap site) was 5'-end-labeled with T4 polynucleotide kinase and 
gel-purified IO5 cpm of this primer was annealed overnight at 30 "C 
to 10 pg of the poly(A+) RNA in 30 p1 of hybridization buffer which 
contained 80% formamide, 40 mM PIPES,  pH 6.4,400 mM NaC1, and 
1 mM EDTA. The nucleic acids were precipitated and resuspended in 
a buffer containing 50 mM Tris-HC1, pH 6.0, 40 mM KC1, 0.5 mM 
EDTA, 5.0 mM MgC12, 5.0 mM DTT,  and 0.25 mM dNTPs. Twenty 
units of avian myeloblastosis virus reverse transcriptase were then 
added, and  the sample was incubated for 3  h at 42 "C. The reaction 
was stopped by adding RNase A (40 pg/ml) and EDTA (20 mM) and 
incubated at 37 "C for 30 min; the products were analyzed on a 6% 
DNA sequencing gel.  Alcohol dehydrogenase mRNA was quantitated 
under identical conditions using 5 pg  of poly(A+) RNA with an 
appropriate primer (37). 
Assay for Copy Number of E2 Plasmids-To determine the copy 
number of the  WT  and  mutant derivatives of the pU4E2CAT in S. 
pombe transformants, total DNA was prepared from a portion of the 
cells used for the primer extension analysis according to Durkacz et 
al. (38). Equal  quantities of DNA  were immobilized on  a nitrocellulose 
filter using the Bio-Rad slot blot apparatus  as described (32) along 
with different copy numbers of purified pU4E2CAT DNA. The filter 
was then hybridized with 32P-labeled random-primed 1.6-kilobase 
DNA fragment coding for the CAT gene, generated by digesting 
pU4E2CAT with XbaI and BglII. The signals in the autoradiogram 
were quantitated by a densitometer, and the copy numbers were 
determined by comparing the signals with that of pU4E2CAT DNA. 
The filter was then reprobed with a DNA fragment coding for the 
single-copy cdc2  gene (38). The copy numbers of the pU4E2CAT in 
the  transformants were normalized with respect to cdc2 gene. 
Partial Purification of a Polypeptide from S. pombe That Binds to 
the E2FSite-S. pombe cells (protease-deficient strain TMO11)  grown 
in YEL media as described above were harvested from logarithmically 
growing culture (10 liters).  The cells were suspended in a lysis buffer 
containing 10 mM Tris-HC1, pH 7.6, 5 mM KCll .5  mM MgC12, 1 mM 
DTT, 1 mM phenylmethylsulfonyl fluoride, 500 units/ml  aprotinin, 1 
pg/ml leupeptin, 1 pg/ml N"-p-tosyl-L-lysine chloromethyl ketone 
(TLCK), 1 pg/ml tosylphenylalanyl chloromethyl ketone (TPCK), 1 
pg/ml antipain,  and 1 pg/ml pepstatin A and broken by vortexing 
with glass beads (500 microns) 6 times for 30 s and centrifuged for 
10 min at 2,500 rpm. The pellet from this step was resuspended in 
the above lysis buffer containing  2 M NaCl and incubated at 4 "C for 
60 min with constant shaking. The lysate was then spun at 2,500 rpm 
for 15 min, and  the  supernatant (nuclear extract) was dialyzed in a 
buffer containing 20  mM Tris-HC1, pH 7.5, 50 mM NaCl, 1 mM 
EDTA, 10% glycerol, and 1 mM DTT (buffer A). All buffers used in 
the purification protocol contained the above-mentioned protease 
inhibitors. The nuclear extracts were then loaded on a heparin- 
agarose column previously equilibrated with buffer A. The column 
was then sequentially washed with buffer A and with buffer A 
containing 0.3 M NaC1. DNA-binding proteins were eluted with buffer 
A  containing 1 M NaCl. The 1 M NaCl eluate of the heparin-agarose 
column was dialyzed in a buffer containing 25 mM Hepes, pH 7.5, 
12.5 mM MgC12, 20% glycerol, 0.1% Nonidet P-40, 1 mM DTT, and 
100 mM KC1 (buffer B).  The dialyzed fraction was  mixed with 20 A 
units of salmon sperm DNA and incubated on ice for 10 min. The 
oligomerized E2F  sites  (ACTAGTTTCGCGCCCTTTCT) as de- 
sample was then applied to a DNA-affinity column that contained 
scribed by Kadonaga and  Tjian (39). The column was  washed with 5 
column volumes of buffer B and  then eluted with buffer B containing 
Bradford (35). 
1 M KCl. Protein concentrations were estimated by the method of 
Preparation of Clarified Extracts from S. pombe-Clarified cell 
extracts were prepared according to  the method of Barker  et al. (40). 
Briefly, logarithmically growing S.  pombe cells (5 X 106/ml) were 
harvested and washed in 0.9% saline, and the cell pellet was sus- 
pended in  5 ml  of a buffer containing 50 mM Tris-HC1, pH 7.5, 5 mM 
EDTA, 0.3 M KC1,0.2% Nonidet P-40,10% glycerol, 2 mM DTT,  and 
0.1 mM phenylmethylsulfonyl fluoride. Cells were then mixed with 
an equal volume of glass beads (500 microns) and disrupted by 
vigorous vortexing 4  times for 30 s. All steps were carried out at 0 to 
4 "C. The cell extracts were clarified by centrifugation at 30,000 X g 
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oligo cloning for 20 min at  4 "C, and  the  supernatants were used for electrophoretic 
mobility shift assays (EMSA) (22). 
Preparation of HeLa Cell Nuclear Extracts-HeLa cells were  grown 
in suspension minimum essential medium containing 7% donor calf 
serum to a density of 6 X lo6 cells/ml and harvested, and  the nuclear 
extract was prepared exactly as described by Dignam et al. (41). 
Briefly, the cells were washed in  phosphate-buffered  saline and re- 
suspended in  2 packed cell volumes of buffer A (10 mM HEPES,  pH 
7.9, 1.5 mM MgCL, 10 mM KCl, and 0.5 mM DTT)  and lysed by 10 
strokes in a  Kontes Dounce glass homogenizer with a B type pestle. 
The nuclei were pelleted by centrifuging the homogenate at 25,000 x 
g for 20 min. The nuclear pellet was then suspended in 3 ml of buffer 
C (20 mM HEPES,  pH 7.9,  25% (v/v) glycerol, 0.42 M NaCl, 1.5 mM 
MgC12, 0.2 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, and 
0.5 mM DTT) per lo9 cells and homogenized with type B pestle (10 
strokes), and this suspension was stirred gently with a magnetic 
stirring  bar for 30 min at 4 "C. It was then centrifuged at 25,000 X g 
for 30 min, and  the  supernatant (nuclear extract) was dialyzed against 
buffer D (20 mM HEPES,  pH 7.9, 20% (v/v) glycerol, 0.1 M KCl, 0.2 
mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, and 0.5 mM DTT) 
and stored at -80 "C. Protein  concentration of the nuclear extract 
was determined by the method of Bradford (35) .  
EMSA-EMSA of the partially purified spE2F was carried out  as 
follows. Approximately 0.3 ng of the 5'-end-labeled oligonucleotide 
which contained the E2F binding site was mixed with 100 ng of 
salmon sperm DNA in  a buffer containing 10 mM Tris-HC1, pH 7.5, 
30 mM NaCl, 1 mM DTT, 1 mM EDTA, 5% glycerol, 1 pg of BSA, 
and 1 to 2 pg  of affinity-purified protein in a total volume of 30 pl. 
The samples were incubated for 30 min at  4 "C, mixed with 3 p1 of 
50% (v/v) glycerol that contained 0.1% marker dyes and 1% Chaps 
(Sigma). The DNA-protein complexes were resolved on 5% native 
polyacrylamide gels. Electrophoresis was carried out at 4 "C using 
Tris-acetate-EDTA buffer (0.7 mM Tris-HC1, pH 7.5, 3.3 mM sodium 
acetate, and 1 mM EDTA). The gels  were dried before autoradiogra- 
phy. EMSAs with the clarified extracts were carried out exactly as 
described (22). EMSAs of human E2F were carried out  as described 
previously with salmon sperm DNA as  the nonspecific competitor 
DNA (42). 
UV Cross-linking-Photochemical cross-linking of the protein to 
the DNA was carried out  as described by Chodosh et al. (43), with 
minor modifications. An aliquot of the EMSA was placed on parafilm 
and irradiated for 4 min at  a  distance of 4.5 cm from a UV source 
(300 nm filter, Fotodyne). Photoadducts were analyzed on a 12% 
SDS-PAGE. The gel  was dried before autoradiography. 
Southwestern Blotting-Fifty rg of protein obtained by 1 M salt 
elution of a heparin-agarose column was separated  on  a 10% SDS- 
polyacrylamide gel and transferred to a nitrocellulose membrane 
(Hybond C, Amersham) using a mini Trans-Blot apparatus. The 
membrane was preincubated for 1 h with a buffer (blocking buffer) 
which contained 5% nonfat dry milk, 10 mM Tris-HC1, pH 7.5, 2 mM 
MgC12, 50 mM NaCl, and 1 mM DTT. The membrane was then 
hybridized overnight at 4 "C with a blocking buffer that contained 
0.2 to 0.4 pg of 5'-end-labeled E2F probe and 200 ng/ml salmon 
sperm DNA. The filters were washed twice after hybridization with 
blocking buffer without NaCl, dried, and autoradiographed (44). 
RESULTS 
Activation of a Reporter Gene by an E2F Site in 5'. pombe- 
To determine whether an E 2 F  site can function as an up- 
stream activator element in S. pombe, we cloned 1 and 2 
copies of an oligonucleotide  containing  the  E2F  recognition 
sequence  upstream of the  TATA motif that drives transcrip- 
tion of a reporter  gene  in an autonomously  replicating  shuttle 
vector. The vector used in this study, pCEH, contains the 
TATA motif fused to coding  sequences for CAT and also the 
autonomously  replicating  yeast  sequence, arsl, and the URA3 
gene  for  selection (33) (Fig. lA). The pCEH vector  also 
contains a polyadenylation  sequence upstream of the TATA 
motif to prevent possible readthrough transcription from 
cryptic  promoters that may be present in the vector  portion 
of the plasmid  into CAT coding sequences (33). The E2F  si te 
was cloned between the polyadenylation sequence and the 
TATA sequence, as shown  in  Fig. L4. For a comparison,  four 
additional  plasmids  with  mutant  E2F  sites  cloned  in the same 
A 
poly .\/core promoter 
B 
WT:  ACTAGTTTCGCGCCCTTTCT- 
M1: ACTAGTTTTXTCCTTTCT - I 
M3: ACTAGAAAAAAAACCTTTCT - 
M4: ACTAGTTTCGCGCgTTTCT - 
MB: ACTAITTTACGTTTCTTTCT -  . . .  
0 0.2 0.4 0.6 0.0 1.0 1.2 1.4 
Relative CAT activity 
FIG. 1. Transcriptional activity of pCEH core  vector (33) 
containing E2F binding sequences. A, diagram of the pCEH 
vector containing the  WT or the  mutant  E2F sites. Oligonucleotides 
containing WT or mutant E2F  sites were inserted at  the polylinker 
site  upstream of the TATA motif of pCEH, such that E2F binding 
sequences are in the same orientation as  that of transcription. See 
"Materials and Methods" for the description of the vector. B, CAT 
activity of the pCEH  variants which contain the  WT  and  the  mutant 
E2F sites and  the sequences of the  WT  and  mutant  E2F oligonucle- 
otides, MI to M6, used in this study. S. pombe cells were transformed 
with pCEH  variants as described (34) and lysed, and  the concentra- 
tion of the protein  in the lysates was determined by the method of 
Bradford (35). CAT activity was then measured with equal quantities 
of protein using the CAT-ELISA kit from Boehringer Mannheim 
under conditions recommended by the vendor. The bar diagram shows 
the average activities for the  mutants relative to WT, obtained from 
three independent experiments. 
location as that of the WT E2F  site  were  constructed.  These 
plasmids are identical  with the pCEH,  which harbors a single 
E2F  site,  except  for  the  mutations  within or outside  the  E2F 
recognition  sequence  (Fig.  1B; bases mutated are underlined). 
Mutants M-1, "3, and M-6  contain  alterations  within  the 
E2F  recognition  sequence and are not  expected  to  function, 
whereas  one mutant, "4, which  contains  alterations  outside 
the E2F  recognition  sequence is expected to function at WT 
levels  (Fig. 1B). S. pombe  cells  were  transformed  with  these 
plasmids, and about  20,000  transformants  in  each  case  were 
pooled  from the plate,  washed, and lysed, and protein  concen- 
trations  were  determined as described  under  "Materials and 
Methods." 0.5 pg of protein  from  each  cell  lysate  was  used  for 
CAT assays.  The  experiment  was  repeated  least  three  times 
for  each  plasmid  in  which the CAT assays  were  carried  out 
from  cell  lysates  prepared  from  newly transformed S. pombe 
cells. In this  approach, which was  also used by  others  (33,36), 
i t  i s  not necessary to determine the copy number of the 
plasmids as equal  quantities of protein  derived  from  nearly 
20,000 pooled transformants were used for comparing the 
CAT protein.  By  pooling a large  number of transformants,  we 
eliminate  interclonal  variations  in the copy  number.  Any  error 
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that may arise in quantitating  the activity of the promoter 
constructs due to variations  in the copy number in the  trans- 
formants  is negligible.  Average CAT activities obtained from 
three independent experiments are shown in Fig. 1B. The 
parent plasmid, pCEH, did not show any CAT activity, 
whereas pCEH, with a single copy of the E2F  site, displayed 
high levels of CAT activity, indicating that  the E2F  site  can 
function  as an upstream  activator  in S. pombe (Fig. 1B). CAT 
activity was  negligible for mutants  M-1  and M-6 in which the 
E2F  site was mutated with multiple base changes. Mutant M- 
3, in which the  E2F site was replaced by contiguous A residues, 
was also defective for transcription; the CAT activity was 
reduced &fold in  this case. In  contrast,  mutant “4, whose 
mutations are outside the E2F recognition site, activated 
transcription to near WT levels. These results show that 
transcriptional  activation of the reporter gene in  pCEH re- 
sults from the  E2F recognition sequence and  not  the presence 
of fortuitous cis-acting elements in the oligonucleotides. When 
2 copies of the  E2F site were cloned in  tandem, CAT activity 
increased 2-fold (data  not  shown).  Thus, we conclude that  the 
E2F  site  can function as  an upstream  activator element in S. 
pombe. 
Requirement of E2F Sites  for Transcription of the Adeno- 
virus E2 Promoter in S. pombe-Because the above results 
showed that the E2F sites can function in S. pombe, we 
determined whether the 2 E2F sites of the adenovirus E2 
promoter  are critical for its expression in S. pombe.  We and 
others have shown that  this  is a  dual, overlapping promoter 
in which transcription starts  at +1, a major cap  site, and -26, 
a minor cap site. These 2 start  sites  are controlled by two 
separate TATA motifs (30, 45, 46). Transcription from the 
major +1 cap site in human cells is dependent on 2 E2F  sites 
and an ATF site  (29,30,42,46-50). Fig. 2 shows the nucleotide 
sequence of the E2 promoter and the +1 (major) and -26 
(minor) cap sites for transcription in human cells. Binding 
sites for transcription  factors ATF and  E2F  and  the TATA 
motifs for the +1 and the -26 promoters are also shown. 
Previous studies have demonstrated that in human cells the 
+1 promoter is the major promoter, which is transcribed  about 
20-fold more efficiently than  the -26 start site, which is a 
minor promoter in human cells (30, 45, 46). We recently 
expressed a chimeric gene in which the E2  promoter is placed 
in  front of the CAT coding sequences after cloning into an 
autonomously replicating yeast  shuttle vector, pURA4. Our 
studies showed that in S. pombe the E2-early promoter is 
transcribed faithfully. However, the relative ratio of transcrip- 
tion from +1 to -26 promoter is reversed; the -26 promoter 
is transcribed about 20-fold more efficiently than the +1 
promoter (51). Nucleotide sequences of the previously char- 
acterized linker-scan mutant promoters that  alter  the ATF 
(LS -74/-85), the proximal (LS -3l/-41), and the distal 
(LS -55/-66) E2F  sites  are shown below the  WT promoter 
L 
4I3 a 40 4 3  
-31141 ................................................. s ..G.I.SG.P ................................... 
-5166 .................... ....LC. m .. ........................................................ 
4/45 ..... .c.G. AICCGG. ............................................................................. 
FIG. 2. Nucleotide sequences of the WT and the LS mutants 
of the adenovirus E2 promoter used in the promoter analysis 
(29, 30). Nucleotides altered  in the  mutant promoters are shown in 
small letters and underlined. Binding sites for transcription  factors 
ATF and E2F and TBP (referred to  as +1 TATA and -26 TATA) 
are shown. Thick arrows indicate the orientation of the E2F sites. 
Thin arrows indicate transcriptional start sites. 
sequence (Fig. 2) (29, 30). These mutants were used in the 
present investigation. Note that mutations in LS -55/-66 
affect the TATA motif of the -26 promoter; the TAAATT 
sequence is changed to CCGGGT. We previously showed that 
in  human cells, within the context of the viral chromosome, 
the TTAAGA sequence around -30, the 2 E2F  sites  present 
in an inverted  orientation and  the ATF site  are all critical for 
the expression of the +1 promoter (30). 
To determine the role of E2F  sites in E2 promoter function 
in S. pombe, the LS mutants described above (Fig. 2) were 
rebuilt into pURA4, and expression of the  mutant promoters 
was quantitated by determining the mRNA levels by the 
primer extension approach. Poly(A+) RNA  was prepared from 
yeast cells transformed with pURA4 containing the  WT and 
mutant promoters  and  annealed with a 5’-end-labeled 27-nt- 
long primer complementary to +110 to +136 (with respect to 
the +1 start site) of the CAT gene. The primer was then 
extended with reverse transcriptase,  and the extended prod- 
ucts were resolved on a DNA sequencing gel. This strategy 
can distinguish between the mRNAs transcribed from the 2 
overlapping promoters. The mRNAs transcribed from the +1 
promoter should generate a 136-nt-long product, whereas 
mRNAs transcribed from the -26 promoter should generate 
a  product 162 nt long. As an internal control, expression of 
the chromosomal alcohol dehydrogenase gene (37) was also 
quantitated using an appropriate primer. The radioactive 
bands  in the autoradiogram were quantitated by a laser den- 
sitometer. Unlike the experiment described above, these ex- 
periments were performed by  growing individual transform- 
ants in large scale cultures. It was therefore necessary to  
determine the copy number of the pU4E2CAT in the  trans- 
formants.  Total DNA from each transformant was prepared 
and hybridized to a DNA fragment that encodes CAT coding 
sequences using the slot blot hybridization approach as de- 
scribed under  “Materials  and Methods.” The copy number of 
pU4E2CAT in  the  total DNA  was determined by including a 
known amount of pU4E2CAT DNA in each experiment. The 
mRNA levels were then normalized to copy number of 
pU4E2CAT in the transformants. Linkerscan mutants -31/ 
-41 and -55/-66 mutate  the proximal and  distal  E2F sites, 
respectively, and, in human cells, these mutants transcribe 
with much reduced efficiency (30).  In S. pombe, transcription 
from LS -31/-41 and -55/-66 was reduced approximately 
4- to 6-fold (Fig. 3  and  Table I) indicating that these 2 E2F 
motifs are  critical for the E2 promoter activity in S. pombe. 
The requirement of the 2 E2F sites for the activity of this 
promoter in S. pombe is not surprising. This promoter has a 
unique architecture in that  the two E2F  sites  are positioned 
in an inverted  orientation  and form a part of a large imperfect 
palindrome. Proper spacing and  orientation of these 2 E2F 
sites  are  critical for the promoter activity in mammalian cells, 
and  E2F  binds to these two sites cooperatively (52).  Mutations 
in any one of the two E2F  sites abolishes its activity (52). As 
in mammalian cells (29, 30,  42,  47-50), the ATF site  appears 
to be critical for the E2 promoter activity in S. pombe. A yeast 
homolog of mammalian ATF has been reported both in S. 
cereuisiae (53, 54) and in S. pombe (54, 55). Transcription 
from the -26 cap  site was also reduced for the 3 LS mutants 
used in this study (Fig. 3). As stated above, LS -55/-66 
mutates the TATA motif of the -26 promoter, which  may be 
a reason for the reduced activity of this  mutant with respect 
to  the -26 promoter. It is also conceivable that  the cis-acting 
motifs of the +1 promoter also control the -26 promoter. 
This aspect was not investigated further. 
Identification of a  Protein in S. pombe Extracts  That Binds 
to the E2F Site-The demonstration that  the E2F  site  can 
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FIG. 3. Primer  extension analysis  to determine the role of 
E2F and ATF sites in the E2 promoter activation. S. pornbe 
cells  were stably  transformed  with  pU4E2CAT  plasmids  containing 
the   WT or the mutant derivatives of E2 promoter fused to CAT 
coding sequences. Poly(A+)  RNAs were prepared  from  transformed 
S. pornbe cells and  annealed  to a CAT  primer (+110 to +136 with 
respect to +1 cap  site) or alcohol dehydrogenase  primer (+86 to +109) 
(37). The  primers were then  extended by reverse  transcriptase  and 
electrophoresed  on a 6% DNA  sequencing gel and  autoradiographed. 
Markers, a 5"end-labeled Hoe111 digest of pBR322  DNA.  Only rele- 
vant portions of the autoradiogram are shown. Primer-extended 
products generated for the two mRNAs from the CAT coding se- 
quences  and  the  alcohol  dehydrogenase  mRNA  are  shown by arrows. 
activate a reporter gene in S. pornbe, combined with the 
observation that 2 E2F  sites  are  required  for  the  E2  promoter 
function  in S. pornbe strongly  supports  the  existence of E2F- 
like activity in S. pornbe. We have used biochemical ap- 
proaches to determine  whether  the S. pornbe cells contain a 
factor that binds to the E2F motif. Nuclear extracts were 
prepared  from a protease-deficient  strain of S. pornbe growing 
a t  logarithmic  phase  and loaded onto a heparin-agarose col- 
umn.  Extreme  caution  was  taken  to  prevent  proteolysis by 
adding a variety of protease  inhibitors  in  all  buffers  during 
purification  (see  "Materials  and  Methods").  The  column  was 
washed with 0.3 M NaCl  and  then  eluted  with 1 M NaC1. The 
fractions were assayed for E2F  binding  activity  with  EMSA 
with  the  E2F  site closer to  the +1 cap  site of the  E2  promoter 
TABLE I 
Normalized values (percentwe of WT) for rnRNAs  transcribed 
from the + I  and the -26 cap sites of the adenovirus E2 
promoter in S. pornbe 
The radioactive hands from the autoradiogram shown in Fig. 3 
were quantitated by a laser  densitometer.  The copy number of the 
pU4E2CAT  plasmid  in  the S. pornbe transformants was determined 
by slot-blot  hybridizations as described  under  "Materials  and  Meth- 
ods," and the signals in the autoradiogram shown in Fig. A were 
normalized to  the copy number. 
- ~~~ ~ 
Promotern 
+1 -26 
W T  100 1 0 0  
Mutants 
LS -311-42 17.0 16.6 
LS -5.51-66 27.0  7 6 
LS -741-85 18 3.9 
~~ 
as a probe  (nucleotide  sequence  corresponding  to -50 to -27; 
Fig. 2). A distinct complex was  detected in EMSA  that could 
be competed  with  the homologous unlabeled oligonucleotide 
containing  an  E2F  site.  There was also high background in 
these gels (data not shown). Therefore, we further purified 
the protein preparation with the DNA-affinity column de- 
scribed by Kadonaga  and  Tjian (39), using  the  above-men- 
tioned  E2F  site DNA. The  protein  fraction from the  heparin- 
agarose column was loaded onto the DNA-affinity column, 
which  was  then  washed  extensively  with a  buffer containing 
0.1 M KC1 and eluted with a buffer containing 1 M KCl. A 
silver-stained gel showed  a prominent band migrating a t  
approximately 30 kDa  (see below);  based on  crude  estimates, 
the protein is not more than 10% of the total protein. We 
have  named  this  protein  as S. pornbe E2F  (spE2F). 
The 1 M eluate of the DNA-affinity column was then 
assayed  for  E2F  binding  activity  in EMSA. A duplex oligo- 
nucleotide  that  contains  the recognition site for the  E2F  (the 
same  as  that used for  the  DNA-affinity  column) was 5'-end- 
labeled and  incubated  with  the  affinity-purified  protein;  the 
DNA-protein complexes were resolved in 5% native PACE. 
A number of unlabeled oligonucleotides that  contain  muta- 
tions  within  and  outside  the  E2F recognition sequence 
TTTCGCGC were  used as  competitors  to  establish  the  spec- 
ificity of the  binding.  These included both  single-base  substi- 
tutions  and  multiple  mutations.  Many of these  mutants were 
also  tested  with  crude  HeLa cell nuclear  extracts for compar- 
ison. Fig. 4 shows  the nucleotide sequence of the  WT  E2F  site 
used as a probe  in  these  studies,  the  different  mutant oligo- 
nucleotides  which  carry  the  mutant  E2F  sites,  and  also  the 
oligonucleotides  which carry  the AP1, NFKR,  and  the  CRER/ 
ATF  binding  sites used in  the  competition  experiments.  The 
ability of these oligonucleotides to compete  with  the WT  E2F 
site  in  EMSA  (results  obtained  from  the  experiments  shown 
in Fig. 5 )  are  also  summarized in Fig. 4. As shown in Fig. 5, a 
DNA-protein complex  (Fig. 5A, lanes 2, 17, 26, and 3.5 ) was 
detected that was competed out efficiently with unlabeled 
homologous oligonucleotide (lanes 3, 4, 18, and  27).  Mutant 
oligonucleotides that  contain  mutations  outside  the  E2F rec- 
ognition  sequence  competed  efficiently ("4, "5, and "14, 
lanes 8, 9, and 24, respectively). Mutant oligonucleotides M- 
1, "2, and M-3 contain several bases mutated within the 
E2F recognition site,  whereas  mutants "8, "10, and "12 
each  contain 2 base  mutations. All  of these  mutants failed to 
compete  with  the  E2F recognition site in EMSA except the 
mutant "10 (see below) (Fig. 5A, lanes 5, 6, 7, f.5, 20, and 
22). Further, oligonucleotides that contain recognition se- 
quences for transcription factors AP1, NFKR, and CRER/ 
ATF (Fig. 4) did  not  compete (Fig. SA, lanes 11-13). Thew 
results  indicate that  the  protein  spE2F  that we identified in 
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BINDING 
E2F SITE S.POMBE HELA 
+1 +8 
WT A A G G A C T A G - C C C T T T C T  + + 
M - l *  G A C T A G T T T I - I C C T T T C T  - ND 
M-2* G ~ T G A T C A A A C G C G C C C T T T C T  - 
M-3' G A C T A G A A A A A A A A C C T T T C T  - ND 
M-4* G A C T A G T T T C G C G C I A T T T C T  + ND 
M-5*  G A L m I T T T C G C G C C C T T T C T  + ND 
M-6* G A C T A O T  T Tl-lC T T T C T - ND 
M-7 A C T A G T T T m G C G C C C T T T C T  + +/- 
" 8  A C T A G T ~ T C G ~ G C C C T T T C T  - - 
M-9 A A G G A C T A G O T T C G C G C C C T T T C T  + + 
"10 A A G G A C T A G T B C G C G C C C T T T C T  + +/- 
M-11 A A G G A C T A G T T T C O C G C C C T T T C T  +/- - 
"12 A A G G A C T A G T T T C G m C C C T T T C T  - - 
"13 A A G G A C T A G T T T C G C G B C C T T T C T  + - 
"14 A A G G A C T B T T T C G C G C C C T T T C T  + + 
"15 A A G G A C T A G H T T C G C G C C C T T T C T  +/- +/- 
"16 A A G G A C T A G T O T C G C G C C C T T T C T  +/- +/- 
"17 A A G G A C T A G T T H C C C G C C C T T T C T  - +/- 
"18 A A G G A C T A G T T T ~ ~ G C G C C C T T T C T  + +/- 
"19 A A G G A C T A G T T T C O C G C C C T T T C T  +/- - 
"20 A A G G A C T A G T T T C G O G C C C T T T C T  - - 
"21 A A G G A C T A G T T T C G C O C C C T T T C T  - - 
"22 A A G G A C T A G T T T C G C G O C C T T T C T  + - 
"23 A A G G A C T A G B T T C G C G C C C T T T C T  +/-  +/- 
"24 A A G G A C T A G T T T C G C G O C C T T T C T  +/- +/- 
FIG. 4. Nucleotide sequences of 
the various oligonucleotides which 
contain  mutations  in the  E2F  site, 
and  the oligonucleotides which con- 
tain AP1, CREB/ATF, and  the NFKB 
binding  sites, used in EMSA as com- 
petitors. Nucleotide sequences of only 
one strand are shown. E2F binding se- 
quences in WT are underlined and num- 
bered from +1 to +8. Mutations are 
shown in boxes. Recognition sequences 
for AP1, CREB/ATF, and NFKB are 
shown in italics. Binding refers to the 
ability to compete in EMSA with WT 
E2F site at 100-fold molar excess. The 
binding data shown here are obtained 
from the experiments shown in Fig. 5. *, 
M-1 to M-6 oligonucleotides contain Sal1 
and PstI sites at the 5' and 3' ends, 
respectively. ND, not determined. 
AP 1 TCGAGCTGCAGCTAGTGATGAGTCAGCCGGATCA - ND 
CREBIATE GATCCCTCCTTGGCTGACGTCAGAGAGAGA - ND 
NEkB GATCCAGAGGGGACTTTCCGAGA - ND 
S. pombe cells recognizes the  E2F binding sequence 
TTTCGCGC  or  a sequence that closely resembles this motif. 
Comparison of the Binding Specificity of spE2F and E2F- 
To better  understand the binding specificity of spE2F, EMSA 
was carried  out  in the presence of a  number of single-base 
substitution mutations of the E2F recognition sequence as 
competitors, and the results were compared with that of 
human E2F. A strict comparison of these  results  is difficult 
because the protein  preparations  in  these 2 cases are  not of 
the same quality. The yeast protein is purified on a DNA- 
affinity column, whereas HeLa cell crude nuclear extracts 
were used as a source of human E2F. Nonetheless, with a few 
exceptions, in general there is a good correlation between 
binding specificity of spE2F and human E2F. There is no 
strict requirement for a specific base in  the +1 position for 
both  human  and S. pombe E2Fs (the bases in  the TTTCGCGC 
sequence are numbered +1 to +8, with the  first T as +l;  this 
numbering is unrelated to cap-site numbering). spE2F binding 
was not impaired when T is changed to A (Fig. 5A, mutant 
"9, lane 19), and  partial binding was observed when T was 
changed to C  or  G (Fig. 5A, mutants "15 and "23, lanes 
28 and 38) (see Fig. 4 for a summary of binding results). The 
nucleotide at +8 also seems to be less critical, although G at 
this position is not preferred (Fig. 5A, mutant "24, lane 39). 
In contrast, human E2F did not bind when this base was 
mutated to T or A (Fig. 5B, mutants "13 and "22, lanes 8 
and 21 ); changing this base to G resulted in partial binding 
(mutant "24, lane 23). Several other minor differences were 
also noted. Specifically, changing G at +5 to A prevented 
mammalian protein binding (Fig. 5B, mutant "19, lane 18), 
whereas this  mutation did not abolish binding to spE2F (Fig. 
5A, lane 32) .  Further, changing T at  +3  to C ("17) prevented 
spE2F binding (Fig. 5A, mutant "17, lane 30) ,  while a weak 
but detectable binding to E2F was observed (Fig. 5B, lane 16). 
The  mutations  in "10, in which 2 consecutive Ts at positions 
+2 and  +3 were changed to A residues, did not affect binding 
of spE2F (Fig. 5A, lane 20), whereas this  mutation resulted 
in partial binding to E2F (Fig. 5B, lane 5).  In summary, 
although  both the yeast and mammalian proteins recognize 
the E2F motif, the two proteins differ in their binding speci- 
ficities in some respects. 
Relationship between spE2F and cdcl0 Protein-As indi- 
cated previously, the  E2F binding sequence has  a weak ho- 
mology with the MCB element which is recognized by the 
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FIG. 5. Competition experiments 
to show the binding specificity of 
spE2F  and  E2F in EMSAs. A duplex 
oligonucleotide which contains the  E2F 
site closer to the +I cap site (WT se- 
quence shown in Fig. 4) of the E2 pro- 
moter was 5"end-labeled and incubated 
either with the S. pornbe protein partially 
purified by a DNA-affinity column or 
crude HeLa cell nuclear extracts  and 
with 100-fold molar excess of unlabeled 
oligonucleotides shown in Fig. 4. The 
DNA-protein  complexes were resolved 
on 5% native PAGE, and the gel was 
dried and autoradiographed. A, EMSA 
with spE2F. R,  EMSA with crude HeLa 
cell nuclear extracts. -P, without pro- 
tein. C, sample without  sequence-specific 
competitor. F, free probe. DNA-protein 
complexes are shown by arrows. The 
band below the E2F band in B is non- 
specific. 
F- 
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cdclO protein  in S. pombe. To  determine  whether  spE2F  is 
related  to  the cdclO protein, clarified  whole  cell extracts were 
prepared  from S. pombe, and  EMSA  was  carried  out  exactly 
as described  (26)  with a  labeled probe  containing 3 copies of 
the  MCB  sequence  cloned  in  tandem (see legend to Fig. 6 for 
the  nucleotide  sequence). As shown  in Fig. 6,  a DNA-protein 
complex was  detected  that could  be competed  out  efficiently 
with  unlabeled homologous  oligonucleotide a t  25- to 50- fold 
molar  excess (Fig. 6,lanes3-6).  In  contrast,  an oligonucleotide 
which contained 3 copies of E2F  site  cloned  in  tandem  did 
not  compete  with  MCB  for  binding  over a range of concentra- 
tions  tested (Fig. 6, lanes 7-10). To confirm that  the DNA- 
protein complex generated  in  the  experiment  shown  in Fig. 6 
is  the  result of the cdclO protein  binding  to  the  MCB  element, 
we repeated these experiments using clarified extracts pre- 
pared  from a ts mutant of cdclO as described by Lowndes et 
al. (26). Extracts  from  both WT  and  ts mutants were prein- 
cubated at 37 "C  for 0, 15, 30, and  60  min before assaying  for 
their binding activities in EMSA. A DNA-protein complex 
specific for the MCB sequence was detected in the case of 
W T  extract  even  after  60  min of preincubation. However, in 
the case of the ts mutant,  preincubation of the  extract  even 
for  15  min  resulted in the  disappearance of the DNA-protein 
complex confirming  that  the complex identified in the  exper- 
iment  shown  in Fig. 6 is the  result of the cdclO protein  (data 
not  shown). 
Molecular Weight of spE2F-To  determine  the molecular 
weight of spE2F, we used UV cross-linking  and  Southwestern 
blot hybridization approaches. The affinity-purified protein 
was  incubated  with  the  end-labeled  E2F  probe used for  EMSA 
under  conditions employed for  EMSA  and  irradiated  with a 
UV source as described by Chodosh et al. (43). The UV- 
irradiated  complexes were resolved on a 12%  SDS-PACE. A 
major band migrating at   the 44-kDa position was observed 
when the sample was irradiated with a UV lamp for an 
increasing  length of time (Fig.  7A). This  band was competed 
out  with  unlabeled homologous  oligonucleotide a t  25- to 50- 
fold molar  excess (Fig. 7R). To establish  the specificity of the 
cross-linking, we incubated  the  sample in the  presence of 2 
duplex oligonucleotides  which contain  mutations in the  E2F 
binding  sites ("2 and  M-6)  and  also  the  transcription  factor 
AP1 binding site (Fig. 4). These mutants did not compete 
with the E2F site for UV cross-linking (Fig. 7C). These 
mutants  also  did  not  compete for the  spE2F  binding in EMSA 
(Fig. 5A, lanes 6, IO, and I 1  ). The molecular  size of the DNA- 
protein complex identified in the UV cross-linkingexperiment 
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is  approximately 44 kDa. After  subtracting  the  molecular size 
of the  probe used  for the UV cross-linking, the molecular size 
of the  spE2F is approximately 30 kDa. As a confirmation, we 
repeated the UV cross-linking experiments with uniformly 
labeled E2F  probe which  was substituted  with  bromodeoxy- 
uridine. After UV cross-linking, the DNA-protein complex 
was  digested with  DNase I, and  the labeled polypeptides were 
analyzed on an SDS-polyacrylamide gel. A 30-kDa labeled 
protein was detected  in  these  experiments, which was  com- 
peted  out  with  an  unlabeled  E2F  site  (data  not  shown).  We 
conclude that a 30-kDa  polypeptide in S. pombe extract  spe- 
1 2 3 4 5 6 7 8 9 1 0  
“-” -“ - - - - 
FIG. 6. EMSA showing  differences  in  binding  specificities 
between the cdclO and  spE2F  proteins. Two pg of protein from 
clarified extracts  prepared from S. pornhe were incubated  with a  5’- 
end-labeled oligonucleotide containing 8 copies of the MCR sequence, 
TCGACAACCCGT, cloned in tandem  exactly as described by 
Lowndes et ul. (22).  DNA-protein  complexes were separated  using a 
native PAGE with Trisborate buffer, and the gel was dried and 
autoradiographed. The MCR-specific complex is  shown by an urrow. 
Lanes 3-6, competition  with  unlabeled  MCR  sequence, 3 copies  cloned 
in  tandem a t   2 5 ,  50-, 100-, and 200-fold molar excess. lanes 7-10, 
competition  with 3 copies of an  E2F  binding  site cloned in  tandem  at 
25-, 50-, loo-, and ZOO-fold molar excess. -P, without protein. C ,  
sample  without  sequence-specific  competitor. 
cifically  recognizes the  E2F  binding site. The UV cross-linking 
studies  also  show a strong  but  diffuse  band below the 26.6- 
kDa  marker which is  competed  out  with  unlabeled  E2F site 
but  not  with  mutant  E2F sites (Fig. 7, R and C). This could 
be due to degradation of spE2F during UV cross-linking. 
Alternatively,  this could also be due  to  the  presence of proteins 
related  to  spE2F in S. pornbe that  bind  to  the  E2F  site with 
high affinity.  This  aspect was not  investigated  further. 
In  an  independent  approach, we used Southwestern  blotting 
to identify  the  proteins from S. pornbe that  bind  to  the  E2F 
motif. Heparin-agarose  column  fractions  eluted a t  1 M NaCl 
were fractionated  on 10% SDS-PAGE,  renatured,  transferred 
to a nitrocellulose  membrane,  and hybridized with a 5’-end- 
labeled double-stranded oligonucleotide containing the E2F 
recognition sequence (44). As shown in Fig. SA, a single 
radiolabeled band corresponding to approximately 30 kDa 
was detected,  suggesting that  the size of the  polypeptide  that 
binds  to  the  E2F  site in S. pornbe is 30  kDa. Consistent  with 
these  results, a major  band  migrating at   the  SO-kDa position 
was detected in silver-stained gels when  the  affinity-purified 
sample was fractionated on SDS-PACE (Fig. 8 R ) .  Another 
major  band  with  equal  intensity  migrating  just below the 30- 
kDa band is also visible in this gel. This protein could be 
related to  spE2F, or it might be a modified form of the  spE2F 
(phosphorylated  form,  for  example).  Several less intense 
bands migrating faster than the 30-kDa band can also he 
detected in this gel. These products were not characterized 
further. 
DISCUSSION 
In  mammalian cells, the  transcription  factor  E2F  binds  to 
several  cellular  proteins,  including  the  tumor  suppressor  gene 
product  Rb (4-8), an  Rb-related  protein, p107, cyclin A, cyclin 
E,  and  the  cdk2  kinase (9-15). Rb  binds  to  E2F in C, phase 
of the cell cycle, whereas p107, cyclin A, and  cdk2  kinase bind 
to  E2F in the S phase of the cell cycle. Currently,  the  signif- 
icance of these  complexes in the cell cycle is not clear. I t  is 
likely that  these  cellular  proteins  modulate  E2F  activity  at 
different  stages of the cell cycle. Furthermore,  regulation of 
the E2F complexes has been observed upon retinoic acid- 
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FIG. 7. Identification of a polypeptide in S. porn& specific for the E2F site  by UV cross-linking. Binding  reactions  contained a 
20-base-pair  5”end-labeled  duplex oligonucleotide that  contained  the  WT  E2F  site (Fig. 4). 100 ng o f  snlmrm sperm DNA, and 1 to 2 pp: of 
the  affinity-purified  spE2F  and were irradiated with a UV source. The  photoadducts were analyzed on a 12?h SDS-PACE.  The geln were 
dried before autoradiography. A, a time  course  experiment  in which the  samples were cross-linked for 0,5, 10, and 15  min before SDS-PAGE. 
R, competition  with  the  unlabeled  E2F site. C, competition  with  unlabeled WT  E2F site, the  mutant  derivatives of the  E2F  site, M - 2  and M -  
6, and  the  AP1  binding  site. For nucleotide sequences of these oligonucleotides see Fig. 4. The numbers at  the top indicate  molar  excess of 
the unlaheled oligonucleotides  used in  the assays. Commercially  availahle  prestained  protein  molecular weight  markern  were uned as ntandards. 
The cross-linked  complexes  are  shown by urrows. 
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FIG. 8. Southwestern blot analysis and silver-stained gels 
of the affinity-purified spE2F show a 30-kDa protein. A, 
Southwestern blot analysis. Approximately 50 pg of protein from 
heparin-agarose column fractions were fractionated by SDS-PAGE, 
renatured, transferred to a nylon membrane, hybridized with ‘lP- 
labeled E2F probe, and autoradiographed. Lanes 1 and 2 are duplicate 
samples. Numbers to the left of lane I indicate the position of the 
molecular weight markers. €3, silver-stained gel for the proteins ob- 
tained from the heparin-agarose column chromatography and the 
DNA-affinity  chromatography. 10 pg of protein from heparin-agarose 
column fraction and 1-2 pg of the affinity-purified protein were 
fractionated on a 12% SDS-PAGE (62) and stained with silver (63). 
Lune I ,  heparin-agarose column fraction. Lune 2. affinity-purified 
fraction. The arrows indicate the 30-kDa  polypeptide. 
induced  tumor cell differentiation  (16).  Given  these  observa- 
tions,  it  is likely that  such a protein would play a fundamental 
role in  the growth of all  eukaryotic cells. 
Two independent approaches suggest the existence of a 
protein in S. pombe that  binds  to  the  E2F motif. First, an 
E2F  site,  when  cloned  upstream of a minimal  promoter,  can 
activate  transcription. Only the oligonucleotides in  which  E2F 
recognition sequences  are  mutated fail to  activate  transcrip- 
tion;  mutations  outside  the  E2F  binding  site  do  not signifi- 
cantly affect activation.  Second,  in S. pombe, as in  mammalian 
cells, the activity of the adenovirus E2 +1 promoter is de- 
pendent  on  the 2 E2F  sites. A protein  fraction  from S. pombe 
nuclear  extracts  purified  using a DNA-affinity  column  binds 
to  an  E2F  site of the  E2  promoter.  Binding  is specific to  the 
E2F recognition sequence  because  mutations  outside  the  bind- 
ing site have little effect on binding, whereas a number of 
mutations  within  the  recognition  sequence  prevent binding. 
A protein of 30-kDa  molecular size cross-links to  the  E2F  site 
in uitro. This  protein  is  much  smaller  than  the  human  E2F 
(56, 57). 
Although there  are a few differences with respect to the 
specificity of recognition of the  E2F motif  by human  E2F  and 
spEPF,  it  is  clear  that  spE2F recognizes a variant of the 8- 
base-pair  E2F  binding  site.  This  is  evident  from  the  compe- 
tition  studies.  For  example,  both  human  and S. pombe E2Fs 
bind  to  variants of the  E2F  motif in  which the  first  base  is T, 
A, or C, whereas  binding  is  considerably  impaired  when T is 
changed to G (see Fig. 4 for a summary of binding  results). 
The  last  base  (the +8 position)  does  not  seem  to be essential 
for spE2F binding because mutation of this base to other 
bases does not  affect  binding,  although G at   this position  is 
less preferred. In contrast, human E2F fails to bind to a 
mutant  E2F  site  in which  C at   the  +8 position  is  changed to 
T or A. Like  the  mammalian  protein,  bases  outside  the  E2F 
motif are  not involved in  spE2F  binding  since 2 of the  mutants 
that  contain  mutations 5’ to  the  E2F  site  and 1 which  contains 
mutations 3’ to  the binding site do not affect binding. We 
have observed other  minor  differences  in  binding specificity 
between S. pombe and  human  E2Fs.  For  example, G at   the  
+5 position  is  required  for  mammalian  protein  binding  (C in 
this  position  was  not  tested  in  this  study),  whereas  the  yeast 
protein  binds  to  mutants  with A or T in this position. An 
accurate  comparison  is  difficult at  present because  a consen- 
sus E2F site has not yet been determined. Although our 
mutational  analysis  is  limited,  these  results suggest that  the 
binding specificity of the  yeast  and  mammalian  proteins  is 
similar  but  not  identical.  It  is possible that  spE2F is an  E2F- 
related  protein. 
Two  sequence  motifs  somewhat  related  to  the  E2F recog- 
nition motif have been identified as  upstream  activator  ele- 
ments  in  several  promoters of the  genes  expressed  under cell 
cycle control in budding yeast. One of these, the MluI cell 
cycle box or MCB, coordinately  regulates a number of genes 
which encode  products  required for DNA  synthesis a t  or near 
the  GI/S  phase  boundary.  Synthetic oligonucleotides contain- 
ing  MCBs  inserted  into  the  appropriate  reporter  plasmids  are 
sufficient for the periodic expression of the  reporter genes, 
indicating  that  MCB  elements  are  responsible for the  coor- 
dinate  regulation  and periodic expression of the  DNA  synthe- 
sis genes  (17, 18). S. cereuisiae cells  contain a protein complex 
called DSC-1, that  specifically binds  to MCR. Transcription 
factors p120 and SWIG are a part of this complex (20-24); 
genetic  studies show that  SWI6  is  directly or indirectly re- 
sponsible  for  the  DSC-1  binding  to  MCB  (21.22).  In  another 
study,  partial  purification of S. cereuisiae extracts  has led to 
the  identification of a 17-kDa  protein,  MCBF,  that  binds  to 
the  MCB  element (58). Currently,  the  relationship  between 
MCBF  and  the SWIG protein is not clear. The MluI cell cycle 
box is also conserved in S. pombe. cdc22, which encodes a 
subunit of the  ribonucleotide  reductase,  is  the  only  gene so 
far  known  to be expressed at  the  G1/S  phase  boundary in S. 
pombe (25). The  promoter of this  gene  contains 7 MCBs  and, 
like S. cereuisiae, synthetic  MCBs  can  confer periodicity to 
reporter  genes  (26). A DSC-1-like  activity  has been detected 
in S. pombe (22),  and  the cdclO gene  product  is  part of this 
complex. The cdclO gene product  appears  to be responsible 
for the regulation of MCB-containing genes  in S. pombe 
because ( a )  cdclO mutants down-regulate the expression of 
the cdc22 gene; ( b )  cell extracts  prepared from  cdclO mutants 
failed to  form a DNA-protein complex in  EMSA  with  MCB 
probes; (c) by supershift  assays,  the cdclO gene  product  has 
been  shown to be a part of the S. pombe DSC-1-like complex 
(22); and ( d )  there is a significant  amino acid sequence 
homology within  the 2 33-amino-acid  repeats of transcription 
factors  SWI4, SWIG, and  the cdclO  gene product  (59).  Inter- 
estingly, in spite of all these observations, cdclO does not 
complement  SWI4  and SWIG gene  products in S. cereukiae 
(59). For  several  reasons, we believe that  the 30-kDa  protein 
identified  in  our  study  is  different  from  the cdclO gene  prod- 
uct. First, the E2F site does not compete with the MCB 
sequence in EMSA even a t  200-fold molar excess (Fig. 6). 
Second, the molecular size of spE2F is much smaller than 
that of the cdclO gene product, which is 85 kDa (60). The 
molecular  size of spE2F  was  confirmed  in  numerous  experi- 
ments by Southwestern blot and UV cross-linking studies. 
Extreme  precautions were taken  to avoid  possible  proteolysis 
during protein purification by adding a variety of protease 
inhibitors. Third, the binding specificity of the spE2F is 
clearly different from that of the S. pombe MCB binding 
protein.  spE2F recognizes a t  least 7 of the 8 bases of the  E2F 
motif,  whereas the  MCB  consists of a palindromic  6-base  pair 
sequence. Binding of spE2F was unaffected when C at  the 
fourth  position of the  TTTCGCGC  sequence was changed to 
A or G. Significant  spE2F  binding  also  was observed  when  G 
at   the  fifth  position was changed  to T or A. In  contrast,  the 
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central CGCG sequence in the MCB sequence has been 
strongly conserved. Indeed, a  recent survey of 40 MCB se- 
quences from different promoters shows the frequency of 30/ 
32 for A in the first position, 31/32 for C in the second 
position, 32/32 for G in the  third position, 31/32 for  C in the 
fourth position, 32/32 for G in  the fifth position, and 32/32 
for G in the sixth position (18). That there is efficient or 
significant binding of spE2F to  mutants TTTAGCGC, 
TTTCTCGC,  TTTGGCGC, and TTTCACGC clearly shows 
that  this protein  is  different from the MCB binding protein. 
spE2F is also different from the newly reported Sctl protein; 
the  Sctl protein probably functions as a heterodimer with 
cdclO protein, and  its molecular size is 72 kDa (27). 
In S. cereuisiae, another complex containing  SWN/SWI6 
proteins  controls  transcription of a  set of genes which includes 
GI cyclins and  the site-specific endonuclease HO; these genes 
are expressed at  the GJS phase boundary (18). The promoters 
of these genes contain  a sequence CACGAAAA which is in 
part complementary to  the E2F motif TTTCGCGC, with the 
exception of C at  +6 of the E2F motif. This motif has  not 
been identified in promoters of fission yeast. Our results show 
that spE2F does not recognize this sequence. The mutant 
TTTCGTGC  (the complement of CACGAAAA; mutant M- 
20, Fig. 4) fails to bind to spE2F (Fig. 5, lune 33). Our  study 
therefore identifies a novel transcription  factor in S. pombe 
that binds to a sequence closely related to  the E2F recognition 
sequence. An activity that binds to  the E2F site was also 
reported in S. cereuisiue recently (61) indicating the conserved 
nature of this  protein.  Currently,  our data  are insufficient to 
establish that  the S. pombe protein that binds to  the  E2F  site 
is a true homolog of mammalian E2F. Nonetheless, the pres- 
ence of such a  protein in s. pombe, together with the obser- 
vation that  E2F  sites  are functional in fission yeast raises the 
possibility that  this protein may perform functions  similar to 
those associated with human E2F. It should now  be possible 
to obtain  a cDNA clone for this protein  and to determine  its 
role in  the growth regulation of S. pombe. These  experiments 
are  in progress. 
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